Table 1

Personalized neoantigen peptides and predicted HLA binding in the enrolled patient

IDMutationGeneHLAPeptide_MTIC50(MT)
chr13_37016372L426RCCNA1HLA-DRB1*12:02SEIVPCLSERHKAYL41.73
chr1_234519474K50NCOA6HLA-DRB1*12:02QWINYFDKRRDYLKF37.43
chr5_54558630V1219EDHX29HLA-A*02:03LLKAELVAGL6.8
chr17_45451923K321NEFCAB13HLA-DRB1*12:02VAGCYLKYKNKNSLS37.16
chr1_225700405A706VENAHHLA-DRB1*12:02EMSALLARRRRIVEK3.24
chr12_25398284G12DKRASHLA-A*02:03KLVVVGADGV38.1
chr19_42907156A857ELIPEHLA-DRB1*12:02ALPLSEPMRRSVSEE536.4
chrX_149828881I 464SMTM1HLA-A*02:03FLSIILDHL6.0
chr5_7878221S216CMTRRHLA-DRB1*12:02RTDLVKSELLHIECQ39.99
chr7_154753273Y738CPAXIP1HLA-DRB1*12:02LKLMAYLAGAKYTGC9.4
chr7_77256204A403GPTPN12HLA-DRB1*12:02PKPVLHMVSSEQHSG57.32
chr1_153751670Y704CSLC27A3HLA-A*02:03FLQEVNVCGV4.1
chr16_18826602I 3507FSMG1HLA-DRB1*12:02SFYNNLVSFASPLVT14.01